Evidence map›Paper›PMID 37946310›Full record

ArticleActa neuropathologica communications2023

Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb.

Jonas Honke, Lucas Hoffmann, Roland Coras, Katja Kobow, Costin Leu, Tom Pieper, Till Hartlieb, Christian G Bien, Friedrich Woermann, Thomas Cloppenborg and 13 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Disease insights from brain somatic mosaicism.Experimental & molecular medicine · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 6 countries.

Jonas HonkeDepartment of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Lucas HoffmannDepartment of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Roland CorasDepartment of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Katja KobowDepartment of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Costin LeuGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Tom PieperCenter for Pediatric Neurology, Neurorehabilitation, and Epileptology, Schoen-Clinic, Vogtareuth, Germany.
Till HartliebCenter for Pediatric Neurology, Neurorehabilitation, and Epileptology, Schoen-Clinic, Vogtareuth, Germany.
Christian G BienDepartment of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.
Friedrich WoermannDepartment of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.
Thomas CloppenborgDepartment of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.
Thilo KalbhennDepartment of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.
Ahmed GaballaDepartment of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.
Hajo HamerPartner of the European Reference Network (ERN) EpiCARE, Barcelona, Spain.
Sebastian BrandnerDepartment of Neurosurgery, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Karl RösslerDepartment of Neurosurgery, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
Arnd DörflerDepartment of Neuroradiology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Stefan RamppDepartment of Neurosurgery, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany.
Johannes R LemkeInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Sara BaldassariInserm, CNRS, APHP, Institut du Cerveau - Paris Brain Institute - ICM, Hôpital de La Pitié Salpêtrière, Sorbonne Université, Paris, France.
Stéphanie BaulacInserm, CNRS, APHP, Institut du Cerveau - Paris Brain Institute - ICM, Hôpital de La Pitié Salpêtrière, Sorbonne Université, Paris, France.
Dennis LalGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Peter NürnbergCologne Center for Genomics (CCG), Medical Faculty of the University of Cologne, University Hospital of Cologne, 50931, Cologne, Germany.
Ingmar BlümckeDepartment of Neuropathology, Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg, Erlangen, Germany. bluemcke@uk-erlangen.de.ORCID 0000-0001-8676-0788
Universitätsklinikum Erlangen · DEBielefeld University · DEBroad Institute · USCentre National de la Recherche Scientifique · FRCleveland Clinic · USLeipzig University · DEParacelsus Medical University · ATSchön Klinik Vogtareuth · DEUniversity of Cologne · DEVienna General Hospital · AT

Funding

Clinical genetics of drug-resistant epilepsy with focal cortical dysplasiaR01NS117544 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DENNIS LAL, Costin Leu · 2021 to 2026
$3.4M
Deutsche Forschungsgemeinschaft Bl421/4-1Deutsche Forschungsgemeinschaft De460333672 - CRC1540 Exploring Brain MechanicsNINDS NIH HHS R01 NS117544
6 · The paper itself

Abstract

Focal cortical dysplasia type II (FCDII) is the most common cause of drug-resistant focal epilepsy in children. Herein, we performed a deep histopathology-based genotype-phenotype analysis to further elucidate the clinico-pathological and genetic presentation of FCDIIa compared to FCDIIb. Seventeen individuals with histopathologically confirmed diagnosis of FCD ILAE Type II and a pathogenic variant detected in brain derived DNA whole-exome sequencing or mTOR gene panel sequencing were included in this study. Clinical data were directly available from each contributing centre. Histopathological analyses were performed from formalin-fixed, paraffin-embedded tissue samples using haematoxylin-eosin and immunohistochemistry for NF-SMI32, NeuN, pS6, p62, and vimentin. Ten individuals carried loss-of-function variants in the GATOR1 complex encoding genes DEPDC5 (n = 7) and NPRL3 (n = 3), or gain-of-function variants in MTOR (n = 7). Whereas individuals with GATOR1 variants only presented with FCDIIa, i.e., lack of balloon cells, individuals with MTOR variants presented with both histopathology subtypes, FCDIIa and FCDIIb. Interestingly, 50% of GATOR1-positive cases showed a unique and predominantly vacuolizing phenotype with p62 immunofluorescent aggregates in autophagosomes. All cases with GATOR1 alterations had neurosurgery in the frontal lobe and the majority was confined to the cortical ribbon not affecting the white matter. This pattern was reflected by subtle or negative MRI findings in seven individuals with GATOR1 variants. Nonetheless, all individuals were seizure-free after surgery except four individuals carrying a DEPDC5 variant. We describe a yet underrecognized genotype-phenotype correlation of GATOR1 variants with FCDIIa in the frontal lobe. These lesions were histopathologically characterized by abnormally vacuolizing cells suggestive of an autophagy-altered phenotype. In contrast, individuals with FCDIIb and brain somatic MTOR variants showed larger lesions on MRI including the white matter, suggesting compromised neural cell migration.

Indexed as

Drug Resistant EpilepsyEpilepsyFocal Cortical DysplasiaMalformations of Cortical DevelopmentChildGenotypeGTPase-Activating ProteinsHumansMalformations of Cortical Development, Group ITOR Serine-Threonine KinasesGTPase-Activating ProteinsMTOR protein, humanNPRL3 protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID37946310
PMCPMC10633947
OpenAlexW4388539389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.